OncoMed Pharmaceuticals Inc 3 SEC Filings

Filed On	Filing
23 Mar 2018	Form 3: Stagg Robert, SVP, Clinical R&D Holds 47,334 shares of Common Stock
20 Mar 2018	Form 3: Li Yvonne, See Remarks Holds 64,952 shares of Common Stock
06 Jan 2016	Form 3: Karsen Perry A, Director No securities owned
26 Jun 2015	Form 3: Winningham Rick E, Director No securities owned
16 Oct 2013	Form 3: Wyzga Michael S, Director No securities owned
17 Jul 2013	Form 3: Vertical Group Lp, 10% owner
17 Jul 2013	Form 3: Lvp Gp I, Llc, 10% owner and 9 others Holds 43,859 shares of Class A Common Stock
17 Jul 2013	Form 3: Presidio Management Group Viii L L C, 10% owner and 2 others
17 Jul 2013	Form 3: Presidio Management Group Viii L L C, 10% owner and 9 others
17 Jul 2013	Form 3: Morgenthaler Partners Vii Lp, 10% owner and 1 other
17 Jul 2013	Form 3: Glaxosmithkline Plc, 10% owner
17 Jul 2013	Form 3: Lasky Laurence, Director No securities owned
17 Jul 2013	Form 3: Root Jonathan D, Director
17 Jul 2013	Form 3: Broderick James W., Director
17 Jul 2013	Form 3: Lasersohn Jack W, Director
17 Jul 2013	Form 3: Gould Terry P, Director
17 Jul 2013	Form 3: Pakianathan Deepika, Director
17 Jul 2013	Form 3: Pollard-Knight Denise, Director
17 Jul 2013	Form 3: Woody James N., Director Holds 21,929 shares of Class A Common Stock
17 Jul 2013	Form 3: Hastings Paul J, Director Holds 283,371 shares of Class A Common Stock

Comments